STING is an essential signaling molecule for DNA and cyclic di-GMP (c-di-GMP)-mediated type I interferon (IFN) production via TANK-binding kinase 1 (TBK1) and interferon regulatory factor 3 (IRF3) pathway. It contains an N-terminal transmembrane region and a cytosolic C-terminal domain (CTD). Here, we describe crystal structures of STING CTD alone and complexed with c-di-GMP in a unique binding mode. The strictly conserved aa 153-173 region was shown to be cytosolic and participated in dimerization via hydrophobic interactions. The STING CTD functions as a dimer and the dimerization was independent of posttranslational modifications. Binding of c-di-GMP enhanced interaction of a shorter construct of STING CTD (residues 139-344) with TBK1. This suggests an extra TBK1 binding site, other than serine 358. This study provides a glimpse into the unique architecture of STING and sheds light on the mechanism of c-di-GMP-mediated TBK1 signaling.
INTRODUCTION
A stimulator of interferon genes (STING) (Ishikawa and Barber, 2008; Ishikawa et al., 2009) , also known as MITA (Zhong et al., 2008 (Zhong et al., , 2009 , ERIS (Chen et al., 2011; Sun et al., 2009) , MPYS (Jin et al., 2008 (Jin et al., , 2010 (Jin et al., , 2011a (Jin et al., , 2011b , and TMEM173, is known to play a vital role in the production of type I IFNs (Barber, 2011; Bowzard et al., 2009; Ishikawa and Barber, 2011; Nakhaei et al., 2010; Saitoh et al., 2010) . The membrane protein STING was initially characterized as a plasma membrane tetraspanner associated with type II major histocompatibility complex (MHC-II) with a function to transduce apoptotic signals during antigen presentation (Jin et al., 2008) . Subsequently, STING is shown to reside predominantly in the endoplasmic reticulum (ER) membrane, where it plays a role in relaying the intracellular DNA-mediated innate signals to type I IFN (IFN-I) production (Ishikawa and Barber, 2008; Ishikawa et al., 2009 ). STINGdeficient (Tmem173 À/À ) cells are defective in IFN-I induction triggered by viral, bacterial, or synthetic DNA and STINGdeficient mice are more sensitive than wild-type (WT) controls when infected with DNA viruses such as HSV-1 (Ishikawa et al., 2009) . Despite the essential role of STING in DNA-mediated IFN-I induction, the mechanisms of its action are less clear and controversial in some cases. First, STING is believed to function as an adaptor molecule activated by cytoplasmic receptors after sensing DNA. One potential cytoplasmic DNA receptor, DDX41, has been shown to form a complex with STING and trigger STING-dependent IFN-I induction . However, the nature of the interaction of STING with DDX41 is not known. Another recent report indicates that STING can directly interact with c-di-GMP (Burdette et al., 2011) , a product released by bacteria such as Listeria monocytogenes. In addition to ER localization, some reports indicate that STING is also located at the outer membrane of mitochondria whereas other studies show that STING is translocated from ER to mitochondria during viral infections (Zhong et al., 2008) . Further, activated STING is believed to mediate IFN-I induction through recruiting cytosolic TANK-binding kinase 1 (TBK1), which phosphorylates and activates interferon regulatory factor 3 (IRF3) (Sun et al., 2009) . However, it is still not clear how STING is activated and how the activated STING triggers the recruitment and activation of TBK1. Interestingly, STING is also subject to a broad range of posttranslational modifications like phosphorylation and ubiquitination by TBK1 and RNF5, respectively (Zhong et al., 2008) . Phosphorylation of STING at S358 by TBK1 is increased after viral infection. This phosphorylation is not only critical for the interaction of STING with TBK1 but also helps STING evoke the immune response (Zhong et al., 2008) . In addition, IFNinducible TRIM56 interacts with and facilitates lysine 63-linked polyubiquitination at K150 of STING, which is proposed as a prerequisite for the recruitment and activation of TBK1 to STING and IFN-I induction after detection of a pathogen's double-strand DNA (dsDNA) (Tsuchida et al., 2010) . This finding raises an interesting question-how does TRIM56 gain access to STING K150? TRIM56 is found in the cytoplasm and is known to interact with the C-terminal domain (CTD) of STING spanning aa 174-379 (Tsuchida et al., 2010) . The aa 153-173 region of STING has been predicted to be a transmembrane region, suggesting that K150 and the CTD of STING reside on opposite sides of the membrane. If this is the case, then how does TRIM56 associate with STING across the membrane and carry out ubiquitination? Another contradictory fact is that a K150R STING mutant is shown to be incapable of associating with TBK1 and is unable to activate the production of IFN-I (Tsuchida et al., 2010) . However, in a previous study the same STING K150R mutant is proposed to activate IFN-stimulation responsive element (ISRE) resulting in production of IFN-I (Zhong et al., 2009) .
Thus, mounting evidence reveals a central role for STING in innate immune responses, prompting us to study its structure and function. Here, we describe the crystal structures of the STING CTD alone and in a complex with c-di-GMP refined to 2.45 Å and 2.15 Å resolution, respectively. Our structural, functional, and mutagenesis studies defined the dimer interface of STING and characterized the structure of c-di-GMP bound to the STING CTD. Insights into the understanding of c-di-GMP-mediated TBK1 signaling are provided.
RESULTS
Crystallization and Structure Determination of STING CTD Full-length STING (aa 1-379) could not be expressed as a soluble protein in E. coli. Our sequence analysis results showed that the aa 153-173 region, reported as the last transmembrane domain (Table S1 available online), is the most conserved region in all species examined (Figures 1A, S1A, and S1B), suggesting an important role for this region in the function of STING. After expression screening of several N-terminal deletion truncations ( Figure 1B ) in E. coli, truncations STINGD (aa 149-379) and STINGD 1-138 (aa 139-379) could be expressed as highly soluble proteins and purified to homogeneity with excellent solution properties as stable homodimers (Figures 1C and S1C) . STINGD 1-138 (aa 139-379) (referred to as STING CTD hereafter) crystallized in space group C222 1 . Se-Met derivative of the proteins were used to determine the phases by Se-SAD method with PHENIX ( Figure S2 ; Adams et al., 2010) . The phases were transferred to a native data set (program CAD) and followed by density modification (program DM) and the model was automatically traced by program Warp (Winn et al., 2011 ). The best model derived from the native data was refined to 2.45 Å resolution with PHENIX and Refmac (Adams et al., 2010; Winn et al., 2011) . All additional crystallographic statistics were summarized in Table 1 . Except for residues 139-151, 227-239, 319-320, and 344-370 , the electron density was clear and permitted unambiguous placement of residues. These missing residues were located in the loop regions, suggesting that they are mobile in the constructs used for this study. To locate the missing residues, B-factor sharpening method was attempted (DeLaBarre and Brunger, 2003; Su et al., 2010) . However, the weak electron densities could not be improved any further.
Thus, construct boundaries based on the conserved regions suggested by sequence alignment, rather than those based on previously predicted transmembrane regions, resulted in protein suitable for structure determination.
Overall Structure of STING CTD Amino acids 152-343 folded into a single domain containing five helices and five strands (Figure 2A ). The N-terminal domain is predicted to fold into four transmembrane helices, so the numbering of helices in the STING aa 152-343 structure starts with helix a5 (Figure 2A ). Helices a5 and a6 (V155-N188) form a long extended helix with only a tyrosine (T167) separating them. Helix a6 is long and bends at P173 along the helical axis, resulting in a change in the direction of the helix (Figure 2A ). Amino acids from helices a5 and a7 are involved in intermolecular hydrophobic interactions. STING CTD contains a single curved sheet made up of five strands (Figure 2A ). Helices a7 and a8 are stacked against the sheet and are inserted between helix a5 and the sheet. Interestingly, part of helix a9 is buried in the concave cavity formed by the sheet (Figure 2A) . A number of salt bridges formed between three glutamic acid and two arginine residues hold the helix a9 firmly inside the cavity. Electron density for the C-terminal end of the protein, aa 344-379, positioned at the end of helix a9 was missing, suggesting that this part of the protein is flexible and probably swings around the tip of helix a9 protruding out of the concave cavity of the sheet.
A Dali (Holm and Rosenströ m, 2010) analysis retrieved a very low structural match with leucine-rich repeat kinase 2 (PDB code 2ZEJ, Z score -4.4, rmsd of 4.0 Å for 162 matching residues with 9% sequence identity). Similarly, a ProFunc (Krissinel and Henrick, 2004) analysis retrieved matches for a small portion of the protein with a number of GTP and DNA binding proteins. However, the overall structure of STING CTD is unique and does not resemble any structures deposited in PDB.
Previous studies propose that the STING aa 153-173 hydrophobic region constitutes the last transmembrane domain (summarized in Table S1 ). From the structure of STING CTD (aa 152-343), this region (aa 153-173) of STING is actually not a transmembrane helix (Figure 2A) . Instead, our studies suggest that the STING aa 1-138 region is transmembrane with the secondary structural elements threading the membrane four times ( Figure S1A ). , mouse (NP_082537), rat (NP_001102592), cattle (NP_001039822), horse (XP_001504275), and pig (NP_001136310). Strictly conserved residues are boxed in white on a red background and highly conserved residues are boxed in red on a white background. The predicted last transmembrane domain is boxed in magenta. At the top of the sequences, a schematic representation of the secondary structure elements of unliganded STING CTD are shown, and every ten residues are indicated with a dot (.). Alignment was generated by ClustalW (Thompson et al., 1994) . The a helix is depicted by a coil and b strand by an arrow. The figure was generated by ESPript (Gouet et al., 1999) . (B) The schematic of human STING domain organization. The numbers indicate residues at the domain boundaries. Amino acids 1-173 contains the predicted five transmembrane domains of STING. The crystals were generated from aa 139-379 (green) and aa 152-343 (red) was observed in the final structure. (C) His-tag removed STING CTD analyzed by analytical ultracentrifugation shows dimeric STING CTD (55 kD) in solution.
STING CTD Forms a Unique Dimeric Structure
Although the asymmetric unit contained one molecule of STING CTD, analysis of the symmetry mates revealed that unliganded STING CTD had crystallized as a dimer, measuring $43 Å in height and $37 Å in diameter (Figures 2B and 2C) . Dimerization occurs via an extensive hydrophobic interface, and the major contact area spans 916.2 Å 2 (9.2%) of surface area per monomer with calculated solvation free energy gain upon formation of the interface (D i G) of 13.4 kcal/mol as determined by PISA (Krissinel and Henrick, 2007) . To rule out the possibility that dimerization might have occurred as an artifact of crystallization, gel filtration and analytical ultracentrifugation analysis were performed to determine the oligomerization state of the protein. Results of both the analyses showed that unliganded STING CTD exists The numbers in parentheses represent values for the highest resolution shell.
as a dimer in solution, which was consistent with the crystal packing analysis ( Figures 1C, 2B , and 2C). Thus, we conclude that STING CTD exists as a homodimer in solution.
Within the dimer, STING CTD monomers were related by a crystallographic 2-fold symmetry axis ( Figure 2C ). The 2-fold axis was located near the junction of the two N-terminal a5 helices. STING CTD dimerizes via helix-helix interactions, with helices a5 and a7 predominantly involved in the intermolecular interactions. Interestingly, residues from helix a5 are the most conserved ( Figure 2D ), suggesting that the mode of dimerization might be very similar across species. Hydrophobic amino acids constituted about 65.5% of the total residues involved in (Table S2) . A symmetry-related stacking interaction between F153 of one chain with the H157 from the other chain seems to stabilize the dimer ( Figure 2E ). In addition, a symmetry-related aryl-sulfur interaction between the p-electron cloud of the indole ring of W161 from helix a5 and the side chain of M271 from helix a6 further contributed to the stabilization of the dimer ( Figure 2E ). These amino acids are absolutely conserved in STING from different organisms ( Figures 1A and  S1A) . A number of weak interactions were also observed between helices a5 and a7. The dimer interface of STING CTD was dominated by hydrophobic interactions with no salt bridges participating in the dimerization. Thus, based on several lines of evidence, we propose that STING CTD exists as a V-shaped dimer even in the absence of a ligand.
c-di-GMP Binds into the Trough at the Dimer Interface
The structure of the binary complex of STING CTD with c-di-GMP was determined in P2 1 space group by cocrystallizing STING CTD with the nucleotide analog ( Figure 3A ). Clear electron density for the c-di-GMP permitted unambiguous modeling of the nucleotide into the structure of STING CTD ( Figure 3B ). Similar to the structure of unliganded STING CTD, several residues at the N terminus, the entire C-terminal region from aa 344 to 379, and the loops connecting strand b2 with b3 and b5 with helix a9 were disordered ( Figure 3A) . One molecule of c-di-GMP bound a dimer of STING CTD. Thus, a dimer seems to be the minimal functional unit of STING as shown in Figure S3 .
Overall, the structure of the c-di-GMP-bound STING CTD closely mirrored the unliganded structure (with rmsd 0.64 Å over main chain atoms between one monomer) with an almost identical dimer interface ( Figure S4A ). One molecule of c-di-GMP bound into the trough formed at the junction of dimerization where its innate 2-fold symmetry axis was coaxial with the noncrystallographic 2-fold symmetry axis of the STING CTD dimer ( Figure 3A ). This resulted in nearly symmetrical interactions for the ribose-phosphate ring with the STING CTD dimer ( Figure 3B ). Interestingly, the loop connecting strand b2 with b3 remained disordered after binding of c-di-GMP ( Figure 3A ). Visual inspection of the superimposition of the unliganded and c-di-GMP complex structures revealed that except for some minor changes, there were no obvious structural rearrangements induced as a result of binding of c-di-GMP. Positions of the loop connecting helix a6 with strand b1 (residues A302-N307) and the region connecting helix a8 with strand b5 (residues N183-A192) seemed to have deviated slightly in the binary complex. Further, strands b2 and b3 (residues F221-Q227 and S241-Y245) together with the disordered loop connecting them had moved toward c-di-GMP upon its binding to STING CTD. Intriguingly, the movements of those two b strands were asymmetrical between monomer A and monomer B. The two b strands in monomer A were closer to the guanine moiety than that seen in monomer B when monomer B was superimposed onto monomer A as shown in Figure S4B . We still do not know why and how c-di-GMP induces such asymmetry, albeit minor, between the two monomers and what is the physiological significance of such a deviation observed in the structure. Such asymmetry has been reported previously for a c-di-GMP riboswitch (Smith et al., 2009) .
The c-di-GMP was seen anchored to the protein mainly by several hydrogen bonding and hydrophobic interactions ( Figure 3C ; Table S3 ). The interaction between ribose-phosphate of GMP with STING CTD was more symmetrical than that of the guanine with STING CTD (compare Figure 3B and Figure 3D ). There were four hydrogen bonds (%3.5 Å ) between the ribosephosphate ring and STING CTD: two pairs formed between O2 of ribose and OG1 of T263 and two pairs formed between O3 of ribose and OG1 of T267 via a water molecule (water 26 and 52, respectively) ( Figure 3B) . Interestingly, the phosphates neither were involved in hydrogen bonding nor were anchored by any basic side chains ( Figure 3B ). The interactions of the two guanines with STING CTD monomers were more deviated from the 2-fold symmetry axis. Both purine rings of c-di-GMP were stacked against the aromatic ring of Y167 ( Figures 3B  and 3D ). OG1 atoms of T263 from two monomers were interacting with N3 and N31 atoms of c-di-GMP via hydrogen bonds, 3.02 and 2.96 Å , respectively ( Figure 3B ). Both amine nitrogen atoms (N21 and N2) of GMP were anchored by hydrogen bonds with two water molecules (water 1 and 9), which formed hydrogen bonds with residues Y163, Y261, and E260 on the other side ( Figures 3C and 3D ). These two water molecules were observed in unliganded STING CTD crystal structure as well. These water-mediated hydrogen bonds probably make STING prefer c-di-GMP over c-di-AMP because c-di-AMP does not have the amine group of GMP ( Figure S4C ). Intriguingly, two extra hydrogen bonds between guanine and two water molecules (water 2 and 3), which were mediated through hydrogen bonds by main chain nitrogen and oxygen atoms of S241 of monomer A, were observed ( Figure 3D, top) . Such extra hydrogen bonds were not observed in monomer B (Figures 3C and 3D, bottom ; Table S3 ). Further, two additional residues (R238 and V239) from monomer A became ordered as a result of the c-di-GMP binding ( Figure 3D, top) . In addition, Y240's side chain swung toward c-di-GMP as shown in Figure 3D (top). These changes upon binding of c-di-GMP were not observed in monomer B.
Thus, binding of c-di-GMP does not induce large conformational changes in STING CTD. Upon close inspection of the c-di-GMP-bound STING, some asymmetrical interactions of STING with the purine rings of c-di-GMP were observed. c-di-GMP was anchored on STING by a combination of hydrophilic, hydrophobic, and water-mediated contacts.
Requirement of STING Self-Association for IFN-b Induction It has been reported that STING dimerization is responsible for self-activation and subsequent downstream signaling (Sun et al., 2009) induction remains unknown. To address this issue, we used our crystal structure to first identify the key residues involved in dimerization and mutated them to disrupt the dimerization of STING. The following mutations were selected: V155R, G158L, W161A, Y164A, and I165R. All the mutants were expressed in E. coli with an N-terminal 6His tag. Mutants V155R, W161A, and Y164A were insoluble even when salvaged with an N-terminal GST tag ( Figure S5A ), suggesting that these mutations probably disrupt the dimerization interface and expose the hydrophobic patches resulting in precipitation of the proteins. The soluble G158L and I165R mutants were further purified by Ni affinity followed by gel filtration chromatography. The size exclusion chromatography (SEC) profile of the mutants indicated a highly aggregated protein when compared to the STING CTD WT. Part of the G158L mutant eluted similar to the STING CTD WT, suggesting that a small portion of G158L mutant remained dimeric ( Figure 4A ).
To test whether the integrity of the dimer of STING was essential for its function, we performed luciferase reporter assay on the full-length mutants and the STING WT in 293T cells. The V155R, W161A, and Y164A mutations of the full-length STING showed no activity as expected. Further, the I165R mutant that could be expressed as soluble protein in E. coli was inactive. The G158L mutation showed partial activity when compared to the STING WT ( Figure S5B ). To further investigate, we performed coimmunoprecipitation assay in 293T cells coexpressing Flagtagged STING and HA-tagged STING or HA-tagged STING G158L. Although STING WT interacted strongly with each other, the STING G158L mutant dramatically lost its ability to interact with WT STING and with G158L mutant itself ( Figure S5C ), corroborating the results of the gel filtration chromatography and the luciferase reporter assay experiments.
A recent study shows that an IFN-inducible tripartite-motif protein (E3 ligase TRIM56) carries out ubiquitination of STING when stimulated by poly(dA:dT). Ubiquitination of STING at K150 results in the dimerization of STING, which is a prerequisite for the recruitment and activation of TBK1 leading to the induction of IFN-I (Tsuchida et al., 2010) . However, based on our structure of the STING dimer, K150 may not play a major role in the dimerization of STING. To test this, we expressed and purified the STING CTD K150A, K150L, and K150R mutants and carried out SEC to determine the oligomerization state of the protein. The results revealed that similar to the STING CTD WT, the mutants existed as dimers in solution ( Figure 4B ). Next, to characterize the importance of K150 for STING dimerization in vivo, we generated K150A, K150L, and K150R mutants of full-length STING in 293T cells. As shown in Figure 4C , all three mutant K150 proteins could bind STING-HA as strongly as did STING-Flag. These results demonstrate that K150 may not be essential for dimerization of STING.
To determine whether the dimerization-deficient mutant had a defect in triggering downstream signaling, we performed luciferase reporter assay in 293T cells expressing STING WT and STING G158L, K150A, K150L, and K150R mutants. Whereas STING WT and STING K150A, K150L, and K150R mutants induced strong activation of the IFN promoter (IFN-b-Luc), the activation of IFN-b-Luc by STING G158L was significantly reduced ( Figure 4D , p < 0.01). To confirm that STING dimerization was required for induction of IFN-I, we generated STING- Figure 4F , p < 0.01). Next, we carried out GST pull-down assays to test the association of STING CTD K150R, K150L, and K150A with TBK1. In addition, we also tested whether G158L, S358A, and a truncated STING containing 139-344 amino acids could associate with TBK1. Both STING CTD WT and the three STING CTD K150 mutants could interact directly with TBK1 ( Figure 5A ). To confirm the interaction in cells, we performed coimmunoprecipitation assay in 293T cells expressing HA-tagged STING and Flag-tagged TBK1 and showed that TBK1 immunoprecipitated together with STING ( Figure 5B ). The other two kinases involved in DNA virus-induced IFN-b production, IKKa and NIK, did not interact with STING ( Figure 5B) . Surprisingly, the three mutants K150A, K150L, and K150R and the dimerization-deficient G158L interacted with TBK1 in a manner similar to the interaction of STING WT with TBK1 ( Figure 5C ), suggesting that dimerization of STING may not be absolutely required for interaction with TBK1. Further, the truncated STING (aa 139-344) and the S358A mutant showed comparatively weaker interaction with TBK1 ( Figure 5A ). More importantly, the inability of dimerization-deficient STING G158L to induce IFN production ( Figure 4E ) in spite of retaining its TBK1 binding ability ( Figure 5C ) suggests that only the dimerized STING-TBK1 interaction can induce IFN-b production.
Human STING CTD Binds c-di-GMP, Resulting in Enhanced Recruitment of TBK1
Recently, the mouse STING was shown to bind c-di-GMP, resulting in the induction of IFN (Burdette et al., 2011) . Based on this result, STING is proposed to function as the sensor in inducing a STING-dependent IFN-I response. Human STING shares about 70% sequence homology with its counterpart from mouse ( Figures 1A and S1A ). To test whether human STING could interact with c-di-GMP, we performed binding studies. ITC and thermal shift assay results showed that human STING bound c-di-GMP with an affinity of $4.4 mM ( Figure 6A ). Both ITC and thermal shift assays could not detect binding of c-di-AMP with STING (Figures 6B and S6A ; Table S4 ). In addition, human STING did not bind GTP or dGTP ( Figure 6B ). Unlike phosphodiesterase (PDE) (Christen et al., 2005; Minasov et al., 2009) , cations, such as Mg 2+ , were not required for c-di-GMP binding to STING ( Figure 6B ), which was consistent with the fact that we could not detect any well-ordered cations associated with c-di-GMP in the complex structure. Further, STING mutants K150R, K150L, K150A, S358A, and a shorter truncation aa 139-344 (G344) bound c-di-GMP similar to STING WT. However, G158L and I165R mutants lost their c-di-GMP binding ability as suggested by thermal shift assays ( Figure S6B and Table S4 ). These mutagenesis results can be explained by inspecting the STING CTD:c-di-GMP complex structure. K150 and S358 are located far away from the dimer interface and c-di-GMP. On the other hand, G158 and I165 are part of the dimer interface and are essential for the formation of the c-di-GMP binding pocket. Next, based on the structure of the binary complex, we mutated residues surrounding c-di-GMP to perturb the binding of the nucleotide analog. c-di-GMP binding ability of STING could be completely abolished by mutating S162 to a tyrosine or glutamic acid ( Figures S6C and S6D ). S162 was located below the ribose ring, in proximity to the phosphate group of c-di-GMP. A longer or wider side chain probably obstructs the docking of c-di-GMP into the binding pocket ( Figure S6E ). When overexpressed in 293T cells, the STING S162Y mutant induced much lower levels of IFN-b than did STING WT, highlighting the importance of this residue in STING-mediated type I interferon production ( Figure S6F ). In contrast, mutating T263 to arginine increased the c-di-GMP binding affinity (0.461 ± 0.053 mM) by about 10-fold (compare Figures 6A and 6C ). This mutation increased the c-di-AMP binding affinity of STING to 8.20 ± 0.553 mM, which was about one half of the affinity of STING WT for c-di-GMP ( Figure 6D ). The side chain of T263 pointed toward one side of guanine, and the other side was stacked against the aromatic ring of Y167 (Figures 3B and 3D) . The mutated longer arginine side chain, together with Y167, sandwiched guanine in the middle, which probably increased STING CTD's affinity for c-di-GMP or c-di-AMP. Mutating Y167 (seen stacked against the guanine ring) to serine resulted in an insoluble protein. I200N mutant of STING has been previously shown to be unable to bind c-di-GMP (Burdette et al., 2011; Sauer et al., 2011) . We attempted to bacterially express STING I200N via different strategies without success, which was consistent with the prediction by SDM server that this mutant was highly unstable (Worth et al., 2011) . Mutating Y240 to alanine, histidine, phenylalanine, or tryptophan had no obvious effect on c-di-GMP binding. Thus, structure-based mutagenesis confirmed an essential role for highly conserved residues like S162, Y167, and T263 in binding c-di-GMP.
How binding of c-di-GMP elicits IFN production by STING is currently unknown. Because TBK1 is central to the activation of NF-kB and IRF3 signaling pathways, we studied the binding of TBK1 with STING in presence of c-di-GMP by using GST pull-down assays. STING interacted more strongly with TBK1 in presence of c-di-GMP than with STING alone ( Figure 6E ). Although c-di-AMP also increased the association of TBK1 with STING, its effectiveness was much lower than that of c-di-GMP. TBK1 is known to phosphorylate STING at S358. To find out whether there were additional TBK1 binding sites on STING, we carried out GST pull-down assays by using truncated STING containing residues 139-344 only. Surprisingly, the truncated STING bound TBK1 strongly in the presence of c-di-GMP, suggesting the presence of additional TBK1 binding sites on STING ( Figure 6E ). Taken together, these results showed that upon binding c-di-GMP, recruitment of TBK1 was enhanced. TBK1 was recruited to a new site that did not involve S358. Thus, phosphorylation of S358 is probably not required for IFN-I production elicited by c-di-GMP.
DISCUSSION
Several aspects of the structure-function studies on STING produced unexpected results. Our initial attempts to express truncations of STING around the previously predicted soluble domain (aa 174-379) in E. coli as stable soluble protein failed. When the highly conserved, predicted last transmembrane domain (aa 153-173) was included in the truncations, a highly soluble and stable STING CTD could be produced. Purified STING CTD preferred to stay dimeric in solution. This result provided a clue that STING might exert its function via homotypic interactions in a manner similar to the symmetric dimerization of TIR domains of TLR10 and MyD88 (Monie et al., 2009 ). The structure of STING CTD provided evidence of a symmetric homotypic interaction and defined the interface of the interaction. The structure of STING CTD does not resemble any known adaptors or proteins involved in innate immune responses and has no structural homologs in PDB.
Although there is a general consensus on the presence of a transmembrane region at the N terminus of STING, the boundaries and the number of transmembrane passes reported for STING are variable. All the reports are in agreement with the proposition that the region encompassing aa 153-173 is the last transmembrane domain. Our structure of STING CTD reveals that this region is cytosolic and part of the dimerization interface. Thus, our structure of STING CTD redefines the boundaries of the transmembrane region of STING. However, it is unclear whether the current structure can formally exclude the possibility that the a5 helix could insert into the membrane in the full-length STING protein and/or mediating STING dimerization in the membrane, although such dramatic conformational changes may not be thermodynamically favorable.
The purified STING K150A, K150L, and K150R mutants exhibited a dimeric assembly in solution and retained their wild-type ability to bind TBK1 and stimulate IFN production as indicated by GST pull-down studies and luciferase reporter assay results. Thus, from our structural and functional data it seems that the minimum physical and functional unit of STING is a dimer because of the presence of a large hydrophobic patch that can be solvent excluded only via dimerization. Further, although a majority of the STING homologs have lysine at position 150, some of the homologs (for example the horse STING) do not have lysine in this position, suggesting that a lysine at position 150 may not be essential for the function. Taken together, these results suggest that ubiquitination of K150 may neither be a prerequisite for dimerization of STING nor necessary for association with TBK1.
Previously, STING has been shown to function as a dimer. By using the structure of dimeric STING CTD, we selected residues for a mutation to disrupt the dimer interface, expecting a loss of function of IFN induction. V155R, W161A, and Y164A, mutants resulted in a complete loss of function of STING. Dimerization-deficient G158L mutant showed partial activity. Thus, our structure-based mutagenesis data support the inference that dimerization of STING is essential for induction of IFN.
c-di-GMP was first reported by Benziman and coworkers as an allosterical activator in the membrane-bound cellulose synthase of Gluconacetobacter xylinus in 1987 (Ross et al., 1987) . c-di-GMP is a ubiquitous second messenger that orchestrates the motile planktonic and sedentary biofilm-associated bacterial ''lifestyles'' (Hengge, 2009) . STING CTD has been shown to specifically recognize c-di-GMP (Burdette et al., 2011) but not GTP or ATP. Inspection of the binary complex of STING CTD with c-di-GMP revealed that there was no space to accommodate the second or third phosphate group of ADP/GDP or ATP/GTP. Therefore, STING has the ability to discriminate between c-di-GMP and host GTP or ATP molecules. Bacteria are also known to use c-di-AMP as a secondary messenger molecule for signaling (Rö mling, 2008) . Such signaling molecules are not present in humans and therefore the human body can sense intrusion by the immunosurveillance pathway. Our structural analysis showed that c-di-AMP could be docked at the same site as c-di-GMP without any steric hindrance as a result of their structural similarity. c-di-AMP does not have the amine group of c-di-GMP that is involved in hydrogen bonding with a ''conserved'' (present in unliganded structure) water molecule. This could explain why STING has stronger binding affinity with c-di-GMP over c-di-AMP. In addition, c-di-AMP has an amino group at C6 position that is opposite in charge to the keto group seen in c-di-GMP, which could further influence the binding of c-di-AMP to STING. In fact, ITC and thermal shift assays did not detect any binding of c-di-AMP with STING. However, mutating T263 to arginine resulted in an affinity for c-di-AMP similar to that seen for c-di-GMP with STING CTD WT. Clearly, further studies are needed to ascertain whether STING signaling is c-di-GMP specific or can be triggered by c-di-AMP too. To find out how binding of c-di-GMP to STING resulted in initiation of downstream events leading to IFN-I production, we compared the structure of the c-di-GMP-bound STING CTD with the structure of the unliganded STING CTD. Surprisingly, comparison of the structures revealed no large-scale conformational changes in STING CTD upon c-di-GMP binding. So far, two different mechanisms of activation via c-di-GMP are known (Schirmer and Jenal, 2009) . One mechanism involves crosslinking domains. For example, c-di-GMP has been shown to exert its effect by crosslinking domains in PleD (Chan et al., 2004) , DgcA (Christen et al., 2006) , and WspR (De et al., 2008) . The second mechanism involves signal-dependent ordering of loops. For example, an NMR study on the PilZ domain containing protein PA4608 revealed that upon binding c-di-GMP, an N-terminal region became ordered (Habazettl et al., 2011) . Because dimerization of STING is not signal dependent, we looked at disordered loops, especially the loop connecting strand b2 with b3. This loop was disordered in all the structures of STING CTD we solved. c-di-GMP binds in proximity; in fact, this loop became partially ordered and moved closer toward c-di-GMP upon its binding. It is tempting to speculate that binding of c-di-GMP to STING CTD makes these this loop more accessible for TBK1 binding. This is partly supported by the fact that recruitment of TBK1 was enhanced in the presence of c-di-GMP. Further studies are warranted to explore this exciting possibility, which would also shed light on whether STING plays distinct roles in c-di-GMP and viral DNA-mediated signaling.
In summary, our structural, functional, and mutagenesis data unravel several hitherto unknown aspects of STING. STING forms homotypic interactions that are essential for stimulation of IFN production. The structures of STING CTD provide detailed molecular insights into the nature of this homotypic architecture. Notably, the structure of STING CTD is very different from any known structure of adaptors or proteins functioning in innate immune responses and therefore STING may represent a novel class of sensors involved in detection of bacterial intrusion. Our protein expression, analytical, and structural evidences revealed that the aa 153-173 region was not a transmembrane region as predicted previously but is a hydrophobic dimer interface. The structure of the binary complex maps the exact location of the c-di-GMP binding site on STING and unveils a unique mode of binding of c-di-GMP to proteins. Structureguided mutagenesis studies showed that STING exists and functions as a dimer. Further, ubiquitination of K150 may not be a prerequisite for dimerization. The c-di-GMP binding pocket is formed via dimerization of STING. We show that binding of c-di-GMP enhances the association of TBK1 with STING. An additional TBK1 binding site, other than the previously reported S358, is probably responsible for c-di-GMP-mediated TBK1 signaling. Although the results further our understanding of the nature of the homotypic interactions of STING essential for stimulation of IFN production, questions on how the signal of intrusion sensed by STING is relayed, leading to recruitment of downstream effector molecules, remain to be investigated.
EXPERIMENTAL PROCEDURES Protein Expression and Purification
Human STING fragments were amplified from a human transcription library (Stratagene, USA) and cloned into pMCSG7 vector (Stols et al., 2002) for expression in E. coli BL21 (DE3). The recombinant protein was purified by Ni-affinity chromatography (QIAGEN, USA) and gel filtration chromatography as described (Liang et al., 2011) .
Crystallization and Data Collection
The initial crystallization conditions were examined with commercially available sparse-matrix screening kits. Hits were optimized by hand. 2 ml hanging drops containing 1 ml protein mixed with 1 ml mother liquor were equilibrated over 300 ml reservoir solution and incubated at 16 C. The STING CTD and c-di-GMP complex was formed by mixing equal molar amounts of STING CTD with c-di-GMP (Biolog, USA) with the same crystallization condition as unliganded STING CTD.
Structure Determination and Analysis
Diffraction data for Se-Met, native, and the binary complex of STING CTD with c-di-GMP were collected at wavelength of 0.9793 Å . Data were indexed and scaled with HKL2000 (Otwinowski and Minor, 1997) . The initial phases were determined by Se-SAD (single-wavelength anomalous dispersion) method (Hendrickson, 1991) . PHENIX AutoBuild was used to rebuild the model with the initial phase (Terwilliger et al., 2008) . Other structures were solved by molecular replacement method with program Phaser (McCoy et al., 2007) . The models were manually improved in Coot (Emsley and Cowtan, 2004) . Refinement was carried out with REFMAC (Murshudov et al., 1997) and PHENIX (Adams et al., 2010) alternately. The quality of the final model was validated with MolProbity . Structures were analyzed with PDBePISA (Protein Interfaces, Surfaces, and Assemblies) (Krissinel and Henrick, 2007) , Dali (Holm and Rosenströ m, 2010) , and ProFunc (Laskowski et al., 2005) .
Immunoblotting and Immunoprecipitation
HEK293T cells were transfected with indicated plasmids with Lipofectamine 2000. 48 hr posttransfection, cells were homogenized. Cell lysates were then incubated with anti-Flag M2 affinity gel or anti-HA affinity gel (Sigma) for 2 hr at 4 C and the immunoprecipitated complexes were separated by SDS-PAGE and blotted with indicated antibodies.
IFN-b Luciferase Reporter Assay
HEK293T cells were transfected with IFN-b firefly luciferase and renilla luciferase reporter plasmids together with STING WT or STING mutants. 48 hr posttransfection, firefly and renilla luciferase activities were determined by a Dual Luciferase Assay System (Promega) and a SIRIUS Luminometer (Berthold Detection Systems) according to the manufacturer's protocol.
Additional Methods
More detailed descriptions of methods for protein expression and purification, protein crystallization, structure refinement and analysis, cells and reagents, real-time quantitative PCR, isothermal titration calorimetry (ITC), GST pulldown, thermal shift, analytical ultracentrifugation, and statistical analysis can be found in the Supplemental Information.
ACCESSION NUMBERS
Coordinates and structure factors for the unliganded and liganded STING CTD have been deposited in the Protein Data Bank under the accession codes 4EF5 and 4EF4, respectively.
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